mmq1
Did you have the same vision earlier this year prior to the huge volume run in March on the news they will conduct the human clinical trials?
Mate they are now well underway with these clinical trials and yet you cant see any possible upward movement in the share price.
If that is so could you please explain the run up to 2 cents in March from lanquishing between .7 and .8 for so long?
Oh dear.
Robsstttaarrrr
